NO174198C - Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav - Google Patents

Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav

Info

Publication number
NO174198C
NO174198C NO905327A NO905327A NO174198C NO 174198 C NO174198 C NO 174198C NO 905327 A NO905327 A NO 905327A NO 905327 A NO905327 A NO 905327A NO 174198 C NO174198 C NO 174198C
Authority
NO
Norway
Prior art keywords
methyl
trifluorobutylcarbamoyl
methylphenylsulfonyl
indol
benzamide
Prior art date
Application number
NO905327A
Other languages
English (en)
Norwegian (no)
Other versions
NO174198B (no
NO905327L (no
NO905327D0 (no
Inventor
Robert Toms Jacobs
Original Assignee
Zeneca Ltd
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Ici Plc filed Critical Zeneca Ltd
Publication of NO905327D0 publication Critical patent/NO905327D0/no
Publication of NO905327L publication Critical patent/NO905327L/no
Publication of NO174198B publication Critical patent/NO174198B/no
Publication of NO174198C publication Critical patent/NO174198C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO905327A 1989-12-11 1990-12-10 Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav NO174198C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898927981A GB8927981D0 (en) 1989-12-11 1989-12-11 Carbamoyl derivative

Publications (4)

Publication Number Publication Date
NO905327D0 NO905327D0 (no) 1990-12-10
NO905327L NO905327L (no) 1991-06-12
NO174198B NO174198B (no) 1993-12-20
NO174198C true NO174198C (no) 1994-04-06

Family

ID=10667774

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905327A NO174198C (no) 1989-12-11 1990-12-10 Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav

Country Status (32)

Country Link
EP (1) EP0432984B1 (ar)
JP (1) JPH0822849B2 (ar)
KR (1) KR100192999B1 (ar)
CN (1) CN1025786C (ar)
AP (1) AP192A (ar)
AT (1) ATE163641T1 (ar)
AU (1) AU642182B2 (ar)
BG (2) BG60015B2 (ar)
CA (1) CA2031897C (ar)
CZ (1) CZ614690A3 (ar)
DE (1) DE69032083T2 (ar)
DK (1) DK0432984T3 (ar)
ES (1) ES2112832T3 (ar)
FI (1) FI95029C (ar)
GB (2) GB8927981D0 (ar)
GR (1) GR3026279T3 (ar)
HK (1) HK1003830A1 (ar)
HR (1) HRP930326B1 (ar)
HU (2) HU210441B (ar)
IE (1) IE904448A1 (ar)
IL (1) IL96621A (ar)
MY (1) MY106363A (ar)
NO (1) NO174198C (ar)
PL (2) PL166516B1 (ar)
PT (1) PT96154B (ar)
RO (1) RO108562B1 (ar)
RU (1) RU2002740C1 (ar)
SI (1) SI9012330A (ar)
SK (1) SK614690A3 (ar)
TW (1) TW219329B (ar)
YU (1) YU48218B (ar)
ZA (1) ZA909898B (ar)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0455596T3 (da) * 1990-05-04 1994-11-28 Ciba Geigy Ag Substituerede indoler
GB9020338D0 (en) * 1990-09-18 1990-10-31 Lilly Industries Ltd Pharmaceutical compounds
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
ES2050611B1 (es) * 1992-10-08 1994-12-16 Ici Plc Una nueva forma fisica de un derivado de carbamoilindol con propiedades antagonistas de leucotrienos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
IL80336A (en) * 1985-10-17 1990-02-09 Ici America Inc Indole or benzopyrazole derivatives,their preparation and pharmaceutical compositions containing them
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process

Also Published As

Publication number Publication date
EP0432984A2 (en) 1991-06-19
PL166516B1 (pl) 1995-05-31
CN1025786C (zh) 1994-08-31
KR910011780A (ko) 1991-08-07
PT96154B (pt) 1998-05-29
EP0432984B1 (en) 1998-03-04
JPH0770061A (ja) 1995-03-14
GB2238790B (en) 1993-06-30
HRP930326B1 (en) 1998-12-31
FI95029B (fi) 1995-08-31
PT96154A (pt) 1991-09-30
CA2031897A1 (en) 1991-06-12
DE69032083D1 (de) 1998-04-09
CZ282068B6 (cs) 1997-05-14
RU2002740C1 (ru) 1993-11-15
RO108562B1 (ro) 1994-06-30
DK0432984T3 (da) 1998-11-30
FI906084A (fi) 1991-06-12
AU642182B2 (en) 1993-10-14
JPH0822849B2 (ja) 1996-03-06
GR3026279T3 (en) 1998-06-30
PL288184A1 (en) 1992-04-21
ZA909898B (en) 1991-08-28
AP9000230A0 (en) 1991-01-31
CN1053604A (zh) 1991-08-07
HU210877A9 (en) 1995-09-28
FI95029C (fi) 1995-12-11
SK278528B6 (en) 1997-08-06
AP192A (en) 1992-06-30
GB2238790A (en) 1991-06-12
BG60015B2 (en) 1993-06-30
HUT56345A (en) 1991-08-28
IL96621A (en) 1994-11-28
YU233090A (sh) 1993-05-28
HU908137D0 (en) 1991-06-28
IL96621A0 (en) 1991-09-16
SK614690A3 (en) 1997-08-06
PL167449B1 (pl) 1995-09-30
NO174198B (no) 1993-12-20
TW219329B (ar) 1994-01-21
NO905327L (no) 1991-06-12
GB8927981D0 (en) 1990-02-14
DE69032083T2 (de) 1998-07-16
YU48218B (sh) 1997-08-22
HRP930326A2 (en) 1996-06-30
KR100192999B1 (ko) 1999-06-15
HK1003830A1 (en) 1998-11-06
SI9012330A (en) 1997-12-31
AU6791790A (en) 1991-06-13
CA2031897C (en) 2001-12-18
ES2112832T3 (es) 1998-04-16
GB9026797D0 (en) 1991-01-30
ATE163641T1 (de) 1998-03-15
FI906084A0 (fi) 1990-12-11
IE904448A1 (en) 1991-06-19
CZ614690A3 (en) 1997-05-14
EP0432984A3 (en) 1992-04-22
HU210441B (en) 1995-04-28
BG50606A3 (en) 1992-09-15
NO905327D0 (no) 1990-12-10
MY106363A (en) 1995-05-30

Similar Documents

Publication Publication Date Title
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO871640D0 (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO874955L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
PT102145A (pt) Derivados de piperazina acetamida, processo para a sua preparacao e composicoes farmaceuticas.
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO174198C (no) Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
AU2333888A (en) A cardioprotective agent and a therapeutic agent for ischemic disease comprising N-containing heterocyclic compounds, and a process for the preparation of the same compounds
TR27058A (tr) 2-azabisiklo (2,2,1) hept-5-ene-2 asetik asid bunun türevleri ve ilgili bilesimleri mezkur bilesimlerin hazirlanmasi usul ve mezkur bilesimlerin n-fosfonometilglisin imali icin kullanilmasi.
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO910372L (no) Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
DE2960627D1 (en) 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
NO882279D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive endo-bicyklo (2,2,1) heptyl-adenosin-derivater.
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.